文献速递泌尿生殖腹部MRCT

直肠内固定装置减少前列腺立体定向放疗中的运动并改善直肠剂量学

Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy.
PubMed 文献 · Br J Radiol · 2019-04-24

PROMETHEUS 多中心临床试验的子研究,对最初入组的 10 例前列腺癌患者在有或无直肠位移装置(RDD)条件下行计划 CT 与 MRI,并用电影 MRI 评估分次内运动及剂量学影响。结果显示无 RDD 时各方向位移随时间增加,有 RDD 时兴趣点相对稳定;RDD 在矢状面显著改善直肠壁、前列腺前部、尖部及底部的前后位移范围,并显著降低直肠 V16、V14、Dmax 及接受 8.5 Gy 的后壁直肠百分比,但未改善靶区剂量学。

要点

  • 无 RDD 时前列腺与直肠兴趣点位移随时间增加,置入 RDD 后位移相对稳定。
  • RDD 显著改善矢状面直肠壁、前列腺前部、尖部及底部的前后位移范围。
  • RDD 显著降低直肠 V16、V14、Dmax 及后壁直肠接受 8.5 Gy 的百分比,但未改善靶区剂量学。

核心结论

  • 前列腺立体定向放疗中使用 RDD 可减少分次内前列腺与直肠运动,且随时间延长改善更明显,同时显著改善直肠壁剂量学。

研究设计与样本

  • PROMETHEUS(ACTRN12615000223538)多中心临床试验的子研究,最初入组 10 例患者,在有或无 RDD 条件下行计划 CT 与 MRI,并用电影 MRI 评估分次内运动及剂量学影响。

关键影像表现/征象

  • 电影 MRI 采用交错 T2 HASTE 序列,矢状面与轴面采集,时间分辨率 5.2 s,采集时长 4.3 min。
  • 无 RDD 时各方向位移随时间进展呈总体增加趋势,有 RDD 时兴趣点相对稳定。
  • 矢状面 RDD 使直肠壁、前列腺前部、前列腺尖部及底部的前后位移范围获得统计学显著改善。

临床应用与阅片要点

  • 作者指出 RDD 显著改善前列腺稳定、直肠稳定及剂量学,但未改善靶区剂量学。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: PROMETHEUS (ACTRN12615000223538) is a multicentre clinical trial investigating the feasibility of 19 Gy in 2 fractions of stereotactic body radiotherapy (SBRT) as a boost technique for prostate cancer. The objective of this substudy was to evaluate intrafraction motion using cine MRI and assess the dosimetric impact of using a rectal displacement device (RDD).

METHODS: The initial 10 patients recruited underwent planning CT and MRI, with and without a RDD. Cine MRI images were captured using an interleaved T2 HASTE sequence in sagittal and axial planes with a temporal resolution of 5.2 s acquired over 4.3 min. Points of interest (POIs) were defined and a validated tracking algorithm measured displacement of these points over the 4.3 min in the anteroposterior, superior-inferior and left-right directions. Plans were generated with and without a RDD to examine the impact on dosimetry.

RESULTS: There was an overall trend for increasing displacement in all directions as time progressed when no RDD was in situ . points of interest remained comparatively stable with the RDD. In the sagittal plane, the RDD resulted in statistically significant improvement in the range of anteroposterior displacement for the rectal wall, anterior prostate, prostate apex and base. Dosimetrically, the use of a RDD significantly reduced rectal V16, V14 and Dmax, as well as the percentage of posterior rectal wall receiving 8.5 Gy.

CONCLUSION: The RDD used in stereotactic prostate radiotherapy leads to reduced intrafraction motion of the prostate and rectum, with increasing improvement with time. It also results in significant improvement in rectal wall dosimetry.

ADVANCES IN KNOWLEDGE: It was found that the rectal displacement device improved prostate stabilization significantly, improved rectum stabilization and dosimetry significantly. The rectal displacement device did not improve target volume dosimetry.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. de Leon J, Jameson MG, Rivest-Henault D, et al. Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy. Br J Radiol. 2019. PMID: 30912956. doi:10.1259/bjr.20190056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。